2m 2m 2m 2m 2m 2m 2m
PRECIGEN (PGEN)
NASDAQ
$5.10-$0.07 (-1.35%)
Price as of Jul 14, 2026 4:01 AM EDT- $1.9BMarket Cap
- 165.13%1-Year Change
- BiotechnologyIndustry
PRECIGEN (PGEN)
$5.10-$0.07 (-1.35%)
PGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.17 | ||
Change | -$0.15 (-2.82%) | ||
Open | $5.25 | ||
High | $5.26 | ||
Low | $5.04 | ||
Previous Close | $5.32 | ||
Volume | 3,042,726 | ||
30-Day Average Volume | 5,461,951 | ||
1-Week Change | -7.68% | ||
1-Month Change | 16.18% | ||
1-Year Change | 165.13% | ||
3-Year Change | 338.14% | ||
5-Year Change | -14.83% | ||
Fundamentals | |||
Shares Outstanding | 356.5M | ||
Total Assets | $138.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $21.8M | ||
Net Income | -$7.9M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$5.0M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $80.6M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -506 | ||
Enterprise Value/Revenue | 91 | ||
P/B | 94 | ||
P/E | -266 | ||
PEG | -4 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue